CGQGX | FTCOX | CGQGX / FTCOX | |
Total Expense Ratio | 0.63 | 1.01 | 62% |
Annual Report Gross Expense Ratio | 0.68 | 1.01 | 67% |
Fund Existence | 7 years | 22 years | - |
Gain YTD | 17.405 | 4.946 | 352% |
Front Load | 6% | 6% | 105% |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 24.4B | 1.02B | 2,383% |
Annual Yield % from dividends | 0.44 | 0.67 | 67% |
Returns for 1 year | 11.51 | 1.40 | 819% |
Returns for 3 years | 61.68 | 44.94 | 137% |
Returns for 5 years | 41.42 | 21.31 | 194% |
Returns for 10 years | N/A | 44.03 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIB | 67.02 | 0.80 | +1.21% |
ProShares Ultra Nasdaq Biotechnology | |||
IQQQ | 44.25 | 0.31 | +0.71% |
ProShares Nasdaq-100 High Income ETF | |||
FENY | 23.84 | 0.15 | +0.63% |
Fidelity MSCI Energy ETF | |||
ILS | 20.21 | 0.04 | +0.19% |
Brookmont Catastrophic Bond ETF | |||
XXCH | 32.39 | N/A | N/A |
Direxion Daily MSCI Em Mkt Ex Chn Bl 2X |